Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Iveson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|January 18, 1992
Pseudomembranous colitis complicating chemotherapyT J Iveson, A Chan
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 5, 2000
Pulmonary tumour emboli: a difficult ante-mortem diagnosisS J Brock, C Fuller, T J Iveson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Response to third-line endocrine treatment for advanced breast cancerT J Iveson, J Ahern, I E Smith
Lancet (London, England)|March 14, 1987
Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonateD I Jodrell, T J Iveson, I E Smith
Lancet (London, England)|May 23, 1987
Myelosuppression after methotrexate, mitoxantrone, and mitomycin CD I Jodrell, T J Iveson, I E Smith
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FUT J Iveson, T Hickish, C Schmitt, et al.
Lancet (London, England)|February 25, 1995
Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancerM Dowsett, S R Johnston, T J Iveson, et al.
Cancer Research|January 15, 1993
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancerT J Iveson, I E Smith, J Ahern, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal womenT J Iveson, I E Smith, J Ahern, et al.
Journal of Hepatology|January 1, 1990
Diclofenac associated hepatitisT J Iveson, N G Ryley, P M Kelly, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|January 18, 1992
Pseudomembranous colitis complicating chemotherapyT J Iveson, A Chan
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 5, 2000
Pulmonary tumour emboli: a difficult ante-mortem diagnosisS J Brock, C Fuller, T J Iveson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Response to third-line endocrine treatment for advanced breast cancerT J Iveson, J Ahern, I E Smith
Lancet (London, England)|March 14, 1987
Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonateD I Jodrell, T J Iveson, I E Smith
Lancet (London, England)|May 23, 1987
Myelosuppression after methotrexate, mitoxantrone, and mitomycin CD I Jodrell, T J Iveson, I E Smith
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FUT J Iveson, T Hickish, C Schmitt, et al.
Lancet (London, England)|February 25, 1995
Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancerM Dowsett, S R Johnston, T J Iveson, et al.
Cancer Research|January 15, 1993
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancerT J Iveson, I E Smith, J Ahern, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal womenT J Iveson, I E Smith, J Ahern, et al.
Journal of Hepatology|January 1, 1990
Diclofenac associated hepatitisT J Iveson, N G Ryley, P M Kelly, et al.
Pageof 2